These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 30293926

  • 1. Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.
    Chen KY, Wang CH, Lin TY, Chang CY, Liu CL, Hsiao YC, Hung CC, Wang NC.
    J Microbiol Immunol Infect; 2019 Oct; 52(5):693-699. PubMed ID: 30293926
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih TT.
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y, Sun J, Kong K, Zhang R, Zhang R, Liu L, Wang J, Shen Y, Wu L, Zheng Z, Sun M, Qi T, Wang Z, Tang Y, Sun J, Song W, Yang J, Xu S, Zhao B, Shan F, Qin A, Lu H, Chen J.
    Arch Osteoporos; 2024 Jul 02; 19(1):56. PubMed ID: 38954143
    [Abstract] [Full Text] [Related]

  • 4. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.
    AIDS; 2018 Nov 28; 32(18):2689-2696. PubMed ID: 30234605
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 28; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 6. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D Study Group.
    AIDS; 2016 Apr 24; 30(7):1059-67. PubMed ID: 26807972
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.
    Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S.
    Osteoporos Int; 2014 Mar 24; 25(3):1071-9. PubMed ID: 24057480
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 12. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z.
    Eur J Med Res; 2018 Apr 17; 23(1):18. PubMed ID: 29665846
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: A Chinese Cross-Sectional Study.
    Meng W, Chen M, Song Y, Zhang H, Xie R, Zhang F.
    J Acquir Immune Defic Syndr; 2022 Jul 01; 90(3):360-368. PubMed ID: 35315797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
    Chisati EM, Constantinou D, Lampiao F.
    PLoS One; 2020 Jul 01; 15(1):e0227893. PubMed ID: 31935270
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Jul 01; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Jul 01; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
    Dalemo S, Eggertsen R, Hjerpe P, Almqvist EG, Boström KB.
    Scand J Prim Health Care; 2018 Jun 01; 36(2):198-206. PubMed ID: 29623754
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
    Sayed-Hassan R, Abazid N, Koudsi A, Alourfi Z.
    Arch Osteoporos; 2016 Jun 01; 11():18. PubMed ID: 27126333
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.